New immunologic and biomarker data supports the potential of ITK inhibition with soquelitinib to increase persistent Treg ...

AI chip company Cerebras will begin trading on the public market Thursday, the first of what is expected to be a handful of ...

(Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of ...

ALTO-207 is a fixed-dose combination of pramipexole, a dopamine D3/D2 agonist with antidepressant activity demonstrated across multiple prior studies, and ondansetron, a 5-HT3 antagonist anti-emetic.

The Salisbury Planning Board recommended a text amendment on data centers in the city on May 12, after two meetings of deliberation and significant public input. This text […] ...

Statistical principles show you don’t need a nefarious plot to explain clusters of missing scientists and lab workers ...

One-time opt-out forms may not fully protect retirees from data broker exposure and elder fraud scams that exploit decades of ...

Analyses supporting the use of digitalis glycosides in patients with heart failure were presented in a Late-Breaking Science ...

The boom in data center construction is taking up much of the supply of high-tech components, especially processor and memory chips. This demand is squeezing consumer device makers, which are having ...

Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company focused on developing novel biologic therapeutic candidates, today announced positive ...